This modulation has been thoroughly demonstrated in the mouse cell line RN2 (KMT2A-rearranged NRASG12D AML) [51, 102], as well as in the human cell line ME-1 (AML harboring the CBFB-MYH11 fusion gene) [105]. This evidence concerns the gene MYH11 and acute myeloid leukemia.